Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Mountz

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Seminars in Nuclear Medicine|December 22, 2015
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of DementiaLaura B Eisenmenger, Eugene J Huo, John M Hoffman, et al.
Synapse (New York, N.Y.)|March 21, 2009
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studiesRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Quantitative Sodium (<sup>23</sup>Na) MRI in Pediatric Gliomas: Initial ExperienceAashim Bhatia, Vincent Kyu Lee, Yongxian Qian, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trialDwight E Heron, Robert L Ferris, Michalis Karamouzis, et al.
Magnetic Resonance Imaging|August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trialsBrenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Journal of Neurotrauma|March 19, 2026
Utility of Amyloid Beta and Tau Positron Emission Tomography Scans for Identifying Early-Stage Neurodegenerative Changes in Former Professional Football Players and Healthy Controls: Results from the Brain Health InitiativeShawn R Eagle, Michael Collins, Anthony P Kontos, et al.
Neuroimage|January 29, 2013
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approachesAnn D Cohen, Wenzhu Mowrey, Lisa A Weissfeld, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Direct Comparison of the Tau PET Tracers <sup>18</sup>F-Flortaucipir and <sup>18</sup>F-MK-6240 in Human SubjectsAlexandra Gogola, Davneet S Minhas, Victor L Villemagne, et al.
Frontiers in Neurology|August 21, 2019
[<sup>18</sup>F]FDG, [<sup>11</sup>C]PiB, and [<sup>18</sup>F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive DeclineDavid O Okonkwo, Ross C Puffer, Davneet S Minhas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2016
Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade GliomaMartin A Lodge, Matthias Holdhoff, Jeffrey P Leal, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Seminars in Nuclear Medicine|December 22, 2015
Advances in PET Imaging of Degenerative, Cerebrovascular, and Traumatic Causes of DementiaLaura B Eisenmenger, Eugene J Huo, John M Hoffman, et al.
Synapse (New York, N.Y.)|March 21, 2009
Positron emission tomography imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-norapomorphine: preliminary evaluation and reproducibility studiesRajesh Narendran, W Gordon Frankle, N Scott Mason, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Quantitative Sodium (<sup>23</sup>Na) MRI in Pediatric Gliomas: Initial ExperienceAashim Bhatia, Vincent Kyu Lee, Yongxian Qian, et al.
International Journal of Radiation Oncology, Biology, Physics|May 26, 2009
Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trialDwight E Heron, Robert L Ferris, Michalis Karamouzis, et al.
Magnetic Resonance Imaging|August 18, 2012
Promise and pitfalls of quantitative imaging in oncology clinical trialsBrenda F Kurland, Elizabeth R Gerstner, James M Mountz, et al.
Journal of Neurotrauma|March 19, 2026
Utility of Amyloid Beta and Tau Positron Emission Tomography Scans for Identifying Early-Stage Neurodegenerative Changes in Former Professional Football Players and Healthy Controls: Results from the Brain Health InitiativeShawn R Eagle, Michael Collins, Anthony P Kontos, et al.
Neuroimage|January 29, 2013
Classification of amyloid-positivity in controls: comparison of visual read and quantitative approachesAnn D Cohen, Wenzhu Mowrey, Lisa A Weissfeld, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2021
Direct Comparison of the Tau PET Tracers <sup>18</sup>F-Flortaucipir and <sup>18</sup>F-MK-6240 in Human SubjectsAlexandra Gogola, Davneet S Minhas, Victor L Villemagne, et al.
Frontiers in Neurology|August 21, 2019
[<sup>18</sup>F]FDG, [<sup>11</sup>C]PiB, and [<sup>18</sup>F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive DeclineDavid O Okonkwo, Ross C Puffer, Davneet S Minhas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 2016
Repeatability of <sup>18</sup>F-FLT PET in a Multicenter Study of Patients with High-Grade GliomaMartin A Lodge, Matthias Holdhoff, Jeffrey P Leal, et al.
Pageof 9